clinical trial · NCT03525405
A Study to Evaluate the Mass Balance of 14C-Napabucasin in Healthy Adult Male Subjects
Sumitomo Pharma America, Inc.·phase1·completed·n = 8
ADMEHealthynapabucasin
brief summary
This is a Phase I, single-center, open-label, single-sequence, study evaluating the absorption, metabolism, and excretion of napabucasin in healthy adult male volunteers using a mixture 14C-radiolabeled and unlabeled material.
started
May 18, 2018
primary completion
Jun 2, 2018
completion
Jun 2, 2018
last updated
Nov 8, 2023
official title
A Phase I, Open Label, Single Dose Study to Evaluate the Mass Balance of 14C-Napabucasin in Healthy Adult Male Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol